{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T11:18:47Z","timestamp":1766747927252,"version":"3.41.2"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T00:00:00Z","timestamp":1673913600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006710","name":"Wayne State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:p>Spinocerebellar Ataxia Type 3 (SCA3) is a member of the family of polyglutamine (polyQ) diseases that are caused by anomalous CAG triplet repeat expansions in several genes. SCA3 results from abnormal polyQ expansion in the deubiquitinase (DUB), ataxin-3 (Atxn3). To understand the role of the different domains of mutant Atxn3 on its pathogenicity, with the hope that they can be explored for therapeutic interventions, we have systematically studied their individual and collective effects on its toxicity. One such domain is ubiquitin-binding site 1 (UbS1) on the catalytic domain of Atxn3; UbS1 is necessary for the enzymatic activity of Atxn3. Here, we investigated the importance of UbS1 on the toxicity of pathogenic Atxn3. We generated transgenic <jats:italic>Drosophila melanogaster<\/jats:italic> lines that express polyQ-expanded Atxn3 with and without a functional UbS1. We found that mutating UbS1 markedly exacerbates the toxicity of pathogenic Atxn3. Additional studies indicated that UbS1 regulates the toxicity of Atxn3 not by affecting its aggregation or sub-cellular localization, but by impacting its role in ubiquitin processing. Our findings provide additional insights into the role of Atxn3\u2019s domains in the pathogenicity of SCA3.<\/jats:p>","DOI":"10.3389\/fnins.2022.1112688","type":"journal-article","created":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T05:24:30Z","timestamp":1673933070000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Ubiquitin-binding site 1 of pathogenic ataxin-3 regulates its toxicity in Drosophila models of Spinocerebellar Ataxia Type 3"],"prefix":"10.3389","volume":"16","author":[{"given":"Matthew V.","family":"Prifti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kozeta","family":"Libohova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Autumn L.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Ling","family":"Tsou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sokol V.","family":"Todi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"32026","DOI":"10.1074\/jbc.M506084200","article-title":"Defining the role of ubiquitin-interacting motifs in the polyglutamine disease protein, ataxin-3.","volume":"280","author":"Berke","year":"2005","journal-title":"J. Biol. Chem."},{"key":"B2","doi-asserted-by":"crossref","first-page":"7418","DOI":"10.1523\/JNEUROSCI.4540-06.2007","article-title":"Nuclear localization of ataxin-3 is required for the manifestation of symptoms in SCA3: In vivo evidence.","volume":"27","author":"Bichelmeier","year":"2007","journal-title":"J. Neurosci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1002\/jnr.24684","article-title":"Degron capability of the hydrophobic C-terminus of the polyglutamine disease protein, ataxin-3.","volume":"98","author":"Blount","year":"2020","journal-title":"J. Neurosci. Res."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-26364-x","article-title":"Expression and regulation of deubiquitinase-resistant, unanchored ubiquitin Chains in Drosophila.","volume":"8","author":"Blount","year":"2018","journal-title":"Sci. Rep."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5638","article-title":"Ubiquitin-binding site 2 of ataxin-3 prevents its proteasomal degradation by interacting with Rad23.","volume":"5","author":"Blount","year":"2014","journal-title":"Nat. Commun."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1038\/sj.emboj.7601043","article-title":"An arginine\/lysine-rich motif is crucial for VCP\/p97-mediated modulation of ataxin-3 fibrillogenesis.","volume":"25","author":"Boeddrich","year":"2006","journal-title":"EMBO J."},{"key":"B7","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1146\/annurev.neuro.26.041002.131425","article-title":"Human neurodegenerative disease modeling using Drosophila.","volume":"26","author":"Bonini","year":"2003","journal-title":"Annu. Rev. Neurosci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1242\/dev.118.2.401","article-title":"Targeted gene expression as a means of altering cell fates and generating dominant phenotypes.","volume":"118","author":"Brand","year":"1993","journal-title":"Development"},{"key":"B9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.brainres.2014.09.064","article-title":"A fruitful endeavor: Modeling ALS in the fruit fly.","volume":"1607","author":"Casci","year":"2015","journal-title":"Brain Res."},{"key":"B10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.pneurobio.2011.11.006","article-title":"Toward understanding Machado-Joseph disease.","volume":"97","author":"Costa Mdo","year":"2012","journal-title":"Prog. Neurobiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1093\/brain\/aww228","article-title":"Unbiased screen identifies aripiprazole as a modulator of abundance of the polyglutamine disease protein, ataxin-3.","volume":"139","author":"Costa","year":"2016","journal-title":"Brain"},{"key":"B12","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/978-3-030-38266-7_10","article-title":"Machado-Joseph disease: A stress combating deubiquitylating enzyme changing sides.","volume":"1233","author":"Dantuma","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0013695","article-title":"Splice isoforms of the polyglutamine disease protein ataxin-3 exhibit similar enzymatic yet different aggregation properties.","volume":"5","author":"Harris","year":"2010","journal-title":"PLoS One"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13051","article-title":"The Machado-Joseph disease deubiquitylase ataxin-3 interacts with LC3C\/GABARAP and promotes autophagy.","volume":"19","author":"Herzog","year":"2020","journal-title":"Aging Cell"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.104535","article-title":"Differential toxicity of ataxin-3 isoforms in Drosophila models of spinocerebellar ataxia type 3.","volume":"132","author":"Johnson","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105516","article-title":"Targeting the VCP-binding motif of ataxin-3 improves phenotypes in Drosophila models of Spinocerebellar Ataxia Type 3.","volume":"160","author":"Johnson","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/cells11071223","article-title":"Drosophila as a model of unconventional translation in spinocerebellar ataxia type 3.","volume":"11","author":"Johnson","year":"","journal-title":"Cells"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.60742","article-title":"Ubiquitin-interacting motifs of ataxin-3 regulate its polyglutamine toxicity through Hsc70-4-dependent aggregation.","volume":"9","author":"Johnson","year":"2020","journal-title":"Elife"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2022.974167","article-title":"al modifications that influence the polyglutamine diseases.","volume":"15","author":"Johnson","year":"","journal-title":"Front. Mol. Neurosci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/ng.101","article-title":"Exploiting position effects and the gypsy retrovirus insulator to engineer precisely expressed transgenes.","volume":"40","author":"Markstein","year":"2008","journal-title":"Nat. Genet."},{"key":"B21","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/jnc.14541","article-title":"Machado-Joseph disease\/spinocerebellar ataxia type 3: Lessons from disease pathogenesis and clues into therapy","volume":"148","author":"Matos","year":"2019","journal-title":"J. Neurochem"},{"key":"B22","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pneurobio.2011.06.007","article-title":"Polyglutamine diseases: The special case of ataxin-3 and Machado-Joseph disease.","volume":"95","author":"Matos","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s10858-006-9092-z","article-title":"Structure validation of the Josephin domain of ataxin-3: Conclusive evidence for an open conformation.","volume":"36","author":"Nicastro","year":"2006","journal-title":"J. Biomol. NMR."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1002\/bip.21210","article-title":"Josephin domain of ataxin-3 contains two distinct ubiquitin-binding sites.","volume":"91","author":"Nicastro","year":"2009","journal-title":"Biopolymers"},{"key":"B25","doi-asserted-by":"publisher","first-page":"10493","DOI":"10.1073\/pnas.0501732102","article-title":"The solution structure of the Josephin domain of ataxin-3: Structural determinants for molecular recognition.","volume":"102","author":"Nicastro","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012430","article-title":"Understanding the role of the Josephin domain in the PolyUb binding and cleavage properties of ataxin-3.","volume":"5","author":"Nicastro","year":"2010","journal-title":"PLoS One"},{"key":"B27","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1242\/dmm.024810","article-title":"Fruit flies on the front line: The translational impact of Drosophila.","volume":"9","author":"Perrimon","year":"2016","journal-title":"Dis. Model. Mech."},{"key":"B28","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s12192-012-0346-2","article-title":"Basal and stress-induced Hsp70 are modulated by ataxin-3.","volume":"17","author":"Reina","year":"2012","journal-title":"Cell Stress Chaperones"},{"key":"B29","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/hmg\/ddp482","article-title":"Proteotoxic stress increases nuclear localization of ataxin-3.","volume":"19","author":"Reina","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"B30","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.nbd.2018.04.013","article-title":"Toxicity and aggregation of the polyglutamine disease protein, ataxin-3 is regulated by its binding to VCP\/p97 in Drosophila melanogaster.","volume":"116","author":"Ristic","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.bbrc.2007.08.062","article-title":"Inactivation of the mouse Atxn3 (ataxin-3) gene increases protein ubiquitination.","volume":"362","author":"Schmitt","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1093\/hmg\/ddx039","article-title":"Interaction of the polyglutamine protein ataxin-3 with Rad23 regulates toxicity in Drosophila models of Spinocerebellar ataxia type 3.","volume":"26","author":"Sutton","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"B33","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s12017-010-8137-3","article-title":"Mouse ataxin-3 functional knock-out model.","volume":"13","author":"Switonski","year":"2011","journal-title":"Neuromolecular. Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"29348","DOI":"10.1074\/jbc.M704126200","article-title":"Cellular turnover of the polyglutamine disease protein ataxin-3 is regulated by its catalytic activity.","volume":"282","author":"Todi","year":"","journal-title":"J. Biol. Chem."},{"key":"B35","doi-asserted-by":"crossref","first-page":"39303","DOI":"10.1074\/jbc.M110.181610","article-title":"Activity and cellular functions of the deubiquitinating enzyme and polyglutamine disease protein ataxin-3 are regulated by ubiquitination at lysine 117.","volume":"285","author":"Todi","year":"2010","journal-title":"J. Biol. Chem."},{"key":"B36","first-page":"257","article-title":"Polyglutamine repeat disorders, including Huntington\u2019s disease","author":"Todi","year":"","journal-title":"Molecular neurology"},{"key":"B37","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/emboj.2008.289","article-title":"Ubiquitination directly enhances activity of the deubiquitinating enzyme ataxin-3.","volume":"28","author":"Todi","year":"2009","journal-title":"EMBO J."},{"key":"B38","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105774","article-title":"Altered retinal structure and function in Spinocerebellar ataxia type 3.","volume":"170","author":"Toulis","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"B39","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108360","article-title":"The deubiquitinating enzyme ataxin-3 regulates ciliogenesis and phagocytosis in the Retina.","volume":"33","author":"Toulis","year":"2020","journal-title":"Cell Rep."},{"key":"B40","doi-asserted-by":"publisher","first-page":"34460","DOI":"10.1074\/jbc.M113.513903","article-title":"Ubiquitination regulates the neuroprotective function of the deubiquitinase ataxin-3 in vivo.","volume":"288","author":"Tsou","year":"2013","journal-title":"J. Biol. Chem."},{"key":"B41","doi-asserted-by":"publisher","first-page":"4385","DOI":"10.1093\/hmg\/ddv174","article-title":"DnaJ-1 and karyopherin alpha-3 suppress degeneration in a new Drosophila model of spinocerebellar ataxia type 6.","volume":"24","author":"Tsou","year":"","journal-title":"Hum. Mol. Genet."},{"key":"B42","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.nbd.2015.05.010","article-title":"The deubiquitinase ataxin-3 requires Rad23 and DnaJ-1 for its neuroprotective role in Drosophila melanogaster.","volume":"82","author":"Tsou","year":"","journal-title":"Neurobiol. Dis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.molcel.2005.02.030","article-title":"Ataxin-3 suppresses polyglutamine neurodegeneration in Drosophila by a ubiquitin-associated mechanism.","volume":"18","author":"Warrick","year":"2005","journal-title":"Mol. Cell"},{"key":"B44","doi-asserted-by":"publisher","first-page":"26436","DOI":"10.1074\/jbc.M803692200","article-title":"The deubiquitinating enzyme ataxin-3, a polyglutamine disease protein, edits K63-linkages in mixed linkage ubiquitin chains.","volume":"283","author":"Winborn","year":"2008","journal-title":"J. Biol. Chem."},{"key":"B45","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3233\/JHD-130058","article-title":"The de-ubiquitinating enzyme ataxin-3 does not modulate disease progression in a knock-in mouse model of Huntington disease.","volume":"2","author":"Zeng","year":"2013","journal-title":"J. Huntingtons Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1534\/genetics.109.112516","article-title":"A genomewide RNA interference screen for modifiers of aggregates formation by mutant Huntingtin in Drosophila.","volume":"184","author":"Zhang","year":"2010","journal-title":"Genetics"}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2022.1112688\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T05:24:37Z","timestamp":1673933077000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2022.1112688\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,17]]},"references-count":46,"alternative-id":["10.3389\/fnins.2022.1112688"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2022.1112688","relation":{},"ISSN":["1662-453X"],"issn-type":[{"type":"electronic","value":"1662-453X"}],"subject":[],"published":{"date-parts":[[2023,1,17]]},"article-number":"1112688"}}